A number of drugs, like sibutramine, which are used clinically in weight control, act on serotonergic metabolism. However, their relation with zinc and free radical (FR) production in central nervous system remains unknown. This study aimed to evaluate the effect of sibutramine and zinc on FR production. Female Wistar rats (about 250 g) were used in this study. The animals received 400 lg ⁄ kg of zinc and 10 mg ⁄ kg of sibutramine intraperitoneally every 36 hr for 15 days. At the end of the study, the rats were killed and their brains used for the measurement of lipid peroxidation thiobarbituric acid-reactive substances (TBARS), reduced glutathione (GSH), hydrogen peroxide (H 2 O 2 ), calcium and 5-hydroxyindole acetic acid (5-HIAA) levels, all by means of validated methods. Corporal weight and food consumption were found to be decreased in the zinc ⁄ sibutramine group. TBARS decreased in cortex, hemispheres and medulla oblongata. GSH decreased in cortex, hemispheres and cerebellum in the sibutramine group. Zinc given alone and in combination with sibutramine decreased H 2 O 2 concentration in cortex, hemispheres and cerebellum but increased calcium and 5-HIAA concentration in all brain regions. Our results suggest that sibutramine and zinc are associated with weight loss, an effect that was more pronounced in the group treated with both drugs. Reduction in oxidative stress may be involved in these effects.Obesity and depression, conditions that were considered a health problem in adults a few years ago, are now recognized as an ordinary disease among young people. In Mexico, the National Nutrition Survey, ENSANUT 2006, reported that the national combined prevalence of overweight and obesity in children from 5 to 11 years of age is about 26% for both sexes, with 26.8% of these being girls and 25.9% boys [1].Recent data from the National Health and Nutrition Examination (USA) have estimated that 17% of the youngsters between 2 and 19 years of age are overweight compared with only 5% found some decades ago [2]. Depression also has an impact on a considerable part of the juvenile population. The prevalence of major depressive disorder has been estimated at 2% in children and 4-8% in adolescents [3].Several studies have pointed out the role played by serotonin not only in obesity but also in depression. Particularly, it has been observed that serotonin plays an important role in the regulation of the processes of satiety and later the ingestion of food and that seasonal changes in the genetic expression of serotonin transporters are related to seasonal appearance of depression in adults [4].On the other hand, it is well known that obesity and depression are accompanied by imbalance between pro-and antioxidant systems of the organism and that this imbalance is related to free radical (FR) generation, which has been associated with the appearance of neurodegenerative diseases to a great extent. In this sense, it has been demonstrated that the serotonergic system also plays an important role in the regulation...